(NYSE:FCN), WASHINGTON, Jan. 12, 2026 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the expansion of its transactions, shareholder activism and issues management capabilities with the appointments of Dan Scorpio and Heather Wilson as Senior Managing Directors within the firm's Strategic Communications segment. “Guiding a transaction from announcement through close has never been […]
(NASDAQ:CHEF), RIDGEFIELD, Conn., Jan. 12, 2026 (GLOBE NEWSWIRE) — The Chefs' Warehouse, Inc. (NASDAQ: CHEF) (the “Company” or “Chefs'”), a premier distributor of specialty food products in the United States, the Middle East and Canada, today announced its preliminary outlook for fiscal year 2026. Following a strong fourth quarter of 2025 and based on current
(NasdaqGM:EDAP), EDAP Announces Preliminary Record Fourth Quarter and Full Year 2025 HIFU Revenue; Issues 2026 Revenue Guidance 36% to 38% Annual YoY HIFU Revenue Growth, Record Performance Driven by Increased Focal One(R) System Sales and Growth in Number of U.S. Focal One Procedures 69% Annual YoY Growth in Focal One System Placements 28% Q4 YoY
(NASDAQ:KNSA), – ARCALYST(R) (rilonacept) 2025 net product revenue of $677.5 million (unaudited), representing ~62% year-over-year growth –– ARCALYST 2026 net product revenue expected to be $900 – $920 million –– KPL-387 Phase 2 recurrent pericarditis data expected in 2H 2026 –– KPL-1161 Phase 1 trial planned to initiate by year end –– Cash balance increased
Volatus to Participate in Investor Conferences and Comments on Shifting U.S. Defense Procurement Priorities GlobeNewswire January 12, 2026 MONTREAL, Jan. 12, 2026 (GLOBE NEWSWIRE) — Volatus Aerospace Inc. (TSXV: FLT; OTCQB: TAKOF; Frankfurt: A3DP5Y/ABB.F) (“Volatus” or the “Company”), a next-generation aerospace and defence company delivering dual-use uncrewed systems, aerial intelligence, and mission-critical operational services, today
Emergent BioSolutions Announces $100 Million Paydown of Term Loan Principal, a Significant Step Achieved Toward its Multi-year Transformation GlobeNewswire January 12, 2026 GAITHERSBURG, Md., Jan. 12, 2026 (GLOBE NEWSWIRE) — Today Emergent BioSolutions, Inc. (NYSE: EBS) announced it made a voluntary prepayment of $100 million under its outstanding term loan facility in late December 2025
Medicus Pharma Ltd. Studies Demonstrate Long-Acting Therapeutic Approach with Stable Bone Turnover in Women The Company's abstract, Evaluation of Teverelix in Healthy Female Volunteers, has been accepted for presentation at American Association of Clinical Endocrinology (AACE) Annual meeting 2026 GlobeNewswire January 12, 2026 PHILADELPHIA, Jan. 12, 2026 (GLOBE NEWSWIRE) — Medicus Pharma Ltd. (NASDAQ: MDCX)
Lexicon Pharmaceuticals Provides a Business and Pipeline Update at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 12, 2026 SONATA-HCM on track for enrollment completion in 2026 and topline data in 2027 $10 million milestone payment triggered from licensing agreement with Novo Nordisk for LX9851 Zynquista on track for NDA resubmission and potential approval
Society Pass Incorporated, NusaTrip Incorporated and Bookcabin Announce Strategic Partnership to Expand Distribution in Projected US$115 Billion Indonesia Travel Market GlobeNewswire January 12, 2026 JAKARTA, Indonesia, Jan. 12, 2026 (GLOBE NEWSWIRE) — Society Pass Incorporated (Nasdaq: SOPA) (the “Company“), Southeast Asia's (SEA) next generation e-commerce ecosystem, and its majority owned subsidiary, NusaTrip Incorporated (Nasdaq: NUTR)
Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results Full year MRD revenue growth of 46% driven by clonoSEQ(R) testing volume GlobeNewswire January 12, 2026 SEATTLE, Jan. 12, 2026 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system